Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200291296> ?p ?o ?g. }
- W4200291296 endingPage "416" @default.
- W4200291296 startingPage "403" @default.
- W4200291296 abstract "A new series of benzoxazole derivatives were designed and synthesised to have the main essential pharmacophoric features of VEGFR-2 inhibitors. Cytotoxic activities were evaluated for all derivatives against two human cancer cell lines, MCF-7 and HepG2. Also, the effect of the most cytotoxic derivatives on VEGFR-2 protein concentration was assessed by ELISA. Compounds 14o, 14l, and 14b showed the highest activities with VEGFR-2 protein concentrations of 586.3, 636.2, and 705.7 pg/ml, respectively. Additionally, the anti-angiogenic property of compound 14b against human umbilical vascular endothelial cell (HUVEC) was performed using a wound healing migration assay. Compound 14b reduced proliferation and migratory potential of HUVEC cells. Furthermore, compound 14b was subjected to further biological investigations including cell cycle and apoptosis analyses. Compound 14b arrested the HepG2 cell growth at the Pre-G1 phase and induced apoptosis by 16.52%, compared to 0.67% in the control (HepG2) cells. The effect of apoptosis was buttressed by a 4.8-fold increase in caspase-3 level compared to the control cells. Besides, different in silico docking studies were also performed to get better insights into the possible binding mode of the target compounds with VEGFR-2 active sites." @default.
- W4200291296 created "2021-12-31" @default.
- W4200291296 creator A5006323337 @default.
- W4200291296 creator A5007786874 @default.
- W4200291296 creator A5020589815 @default.
- W4200291296 creator A5026432056 @default.
- W4200291296 creator A5029891269 @default.
- W4200291296 creator A5035913177 @default.
- W4200291296 creator A5041373551 @default.
- W4200291296 creator A5048133390 @default.
- W4200291296 creator A5048991764 @default.
- W4200291296 creator A5055998450 @default.
- W4200291296 creator A5075447277 @default.
- W4200291296 date "2021-12-27" @default.
- W4200291296 modified "2023-10-11" @default.
- W4200291296 title "New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and <i>in silico</i> studies" @default.
- W4200291296 cites W1416958482 @default.
- W4200291296 cites W1971318845 @default.
- W4200291296 cites W1976423689 @default.
- W4200291296 cites W1980251946 @default.
- W4200291296 cites W1983790923 @default.
- W4200291296 cites W1992591040 @default.
- W4200291296 cites W1992905076 @default.
- W4200291296 cites W2000000541 @default.
- W4200291296 cites W2055265038 @default.
- W4200291296 cites W2056709339 @default.
- W4200291296 cites W2111254482 @default.
- W4200291296 cites W2113595687 @default.
- W4200291296 cites W2114918609 @default.
- W4200291296 cites W2143926802 @default.
- W4200291296 cites W2150048971 @default.
- W4200291296 cites W2164030122 @default.
- W4200291296 cites W2411726279 @default.
- W4200291296 cites W2538465384 @default.
- W4200291296 cites W2576376115 @default.
- W4200291296 cites W2733930358 @default.
- W4200291296 cites W2785579854 @default.
- W4200291296 cites W2796152634 @default.
- W4200291296 cites W2884126108 @default.
- W4200291296 cites W2889072707 @default.
- W4200291296 cites W2939027651 @default.
- W4200291296 cites W2958973731 @default.
- W4200291296 cites W2970998011 @default.
- W4200291296 cites W2979647576 @default.
- W4200291296 cites W2988361120 @default.
- W4200291296 cites W2997414507 @default.
- W4200291296 cites W3014033393 @default.
- W4200291296 cites W3026346415 @default.
- W4200291296 cites W3039947924 @default.
- W4200291296 cites W3081465438 @default.
- W4200291296 cites W3081848457 @default.
- W4200291296 cites W3082495518 @default.
- W4200291296 cites W3085080249 @default.
- W4200291296 cites W3090959428 @default.
- W4200291296 cites W3096002562 @default.
- W4200291296 cites W3098241977 @default.
- W4200291296 cites W3103854394 @default.
- W4200291296 cites W3112436986 @default.
- W4200291296 cites W3113558763 @default.
- W4200291296 cites W3133431544 @default.
- W4200291296 cites W3133533360 @default.
- W4200291296 cites W3157791576 @default.
- W4200291296 cites W3157903393 @default.
- W4200291296 cites W3157992644 @default.
- W4200291296 cites W3159182064 @default.
- W4200291296 cites W3159203841 @default.
- W4200291296 cites W3163986876 @default.
- W4200291296 cites W3174095671 @default.
- W4200291296 cites W3187698246 @default.
- W4200291296 cites W3202421739 @default.
- W4200291296 cites W3208102345 @default.
- W4200291296 doi "https://doi.org/10.1080/14756366.2021.2015343" @default.
- W4200291296 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34961427" @default.
- W4200291296 hasPublicationYear "2021" @default.
- W4200291296 type Work @default.
- W4200291296 citedByCount "78" @default.
- W4200291296 countsByYear W42002912962022 @default.
- W4200291296 countsByYear W42002912962023 @default.
- W4200291296 crossrefType "journal-article" @default.
- W4200291296 hasAuthorship W4200291296A5006323337 @default.
- W4200291296 hasAuthorship W4200291296A5007786874 @default.
- W4200291296 hasAuthorship W4200291296A5020589815 @default.
- W4200291296 hasAuthorship W4200291296A5026432056 @default.
- W4200291296 hasAuthorship W4200291296A5029891269 @default.
- W4200291296 hasAuthorship W4200291296A5035913177 @default.
- W4200291296 hasAuthorship W4200291296A5041373551 @default.
- W4200291296 hasAuthorship W4200291296A5048133390 @default.
- W4200291296 hasAuthorship W4200291296A5048991764 @default.
- W4200291296 hasAuthorship W4200291296A5055998450 @default.
- W4200291296 hasAuthorship W4200291296A5075447277 @default.
- W4200291296 hasBestOaLocation W42002912961 @default.
- W4200291296 hasConcept C104317684 @default.
- W4200291296 hasConcept C109316439 @default.
- W4200291296 hasConcept C154317977 @default.
- W4200291296 hasConcept C159110408 @default.
- W4200291296 hasConcept C178790620 @default.
- W4200291296 hasConcept C185592680 @default.
- W4200291296 hasConcept C190283241 @default.